ISM1 and pulmonary fibrosis: Our data indicated that ISM1 functions as a lung resident inflammation suppressor, protecting the lung from excessive inflammatory responses during LPS-induced ALI and suppresses post-ALI lung fibrosis, likely by suppressing LPS triggered NF-κB activation and proinflammatory cytokine/chemokine production.